SA vaccine production ability gets major boost with new CT hub

President Cyril Ramaphosa, and South African-born health technologies billionaire, Doctor Patrick Soon-Shiong, have unveiled the vaccine manufacturing campus in Cape Town.

President Cyril Ramaphosa and NantWorks founder, Dr Patrick Soon-Shiong, at the launch of the NantSA vaccine manufacturing campus at Brackengate in Cape Town on 19 January 2022. Picture: Kevin Brandt/Eyewitness News

CAPE TOWN - South Africa's vaccine and medicine production capabilities have been given a boost with the launch of the NantSA biopharmaceutical production hub.

President Cyril Ramaphosa, and South African-born health technologies billionaire, Doctor Patrick Soon-Shiong, have unveiled the vaccine manufacturing campus in Cape Town.

Besides focusing on vaccine production, the 25,000 square meter manufacturing NantSA facility is also set to focus on producing other medicinal drug therapies for the country and the continent.

Soon-Shiong, founder of multinational conglomerate, NantWorks, has stressed the need for South Africa to become self-reliant in terms of local biopharmaceutical production.

President Ramaphosa said that this coalition would help Africa address its health challenges.

"Bit by bit those colonial chains are being broken. Today we have broken some of those links. We thank you very much son of South Africa, Dr Patrick Soon-Shiong," the president said.

The goal is to produce a billion doses of COVID-19 vaccines by the year 2025.